FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jean-Yves Delattre

Research Profile

Disorders

Concepts & Ideas

Anatomy

Chromosomes, Human, Pair 1

Procedures

Combined Modality Therapy

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Anna Luisa Di Stefano; Victor Enciso-Mora; Khê Hoang-Xuan; Richard S Houlston; Ahmed Idbaih; Marianne Labussière; Yannick Marie; Karima Mokhtari; Blandine Boisselier; Jean-Yves Delattre; Virginie Desestret; Marc Sanson
Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies.
Xiao-Wei Wang; Matthias Simon; Blandine Boisselier; Jean-Yves Delattre; Konstantinos Gousias; Khê Hoang-Xuan; Ahmed Idbaih; Marianne Labussière; Yannick Marie; Karima Mokhtari; Marta Rossetto; Marc Sanson
Prognostic impact of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in malignant gliomas.
Agustí Alentorn; Blandine Boisselier; Catherine Carpentier; Jean-Yves Delattre; Marine Giry; Khê Hoang-Xuan; Marianne Labussière; Yannick Marie; Karima Mokhtari; Marc Sanson; Ahmed Idbaih
Prevalence, clinico-pathological value, and co-occurrence of PDGFRA abnormalities in diffuse gliomas.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jean-Yves Delattre (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Anna Luisa Di Stefano; Victor Enciso-Mora; Khê Hoang-Xuan; Richard S Houlston; Ahmed Idbaih; Marianne Labussière; Yannick Marie; Karima Mokhtari; Blandine Boisselier; Jean-Yves Delattre; Virginie Desestret; Marc Sanson
Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies.
Neuro-oncology 2013;15(5):542-7.
2013: Xiao-Wei Wang; Matthias Simon; Blandine Boisselier; Jean-Yves Delattre; Konstantinos Gousias; Khê Hoang-Xuan; Ahmed Idbaih; Marianne Labussière; Yannick Marie; Karima Mokhtari; Marta Rossetto; Marc Sanson
Prognostic impact of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in malignant gliomas.
Cancer 2013;119(4):806-13.
2012: Agustí Alentorn; Blandine Boisselier; Catherine Carpentier; Jean-Yves Delattre; Marine Giry; Khê Hoang-Xuan; Marianne Labussière; Yannick Marie; Karima Mokhtari; Marc Sanson; Ahmed Idbaih
Prevalence, clinico-pathological value, and co-occurrence of PDGFRA abnormalities in diffuse gliomas.
Neuro-oncology 2012;14(11):1393-403.
2012: Blandine Boisselier; Pietro Ciccarino; Jean-Yves Delattre; Jaime Gállego Pérez-Larraya; Marianne Labussière; Yannick Marie; Marta Rossetto; Marc Sanson
Detection of IDH1 mutation in the plasma of patients with glioma.
Neurology 2012;79(16):1693-8.
2012: Maïté Verreault; Jean-Yves Delattre; Ahmed Idbaih
[Adult diffuse glioma: genetic heterogeneity and therapeutic implications].
Médecine sciences : M/S 2012;28(10):813-6.
2012: Benjamin Ribba; Damien Ricard; Michel Tod; Branka Cajavec-Bernard; Vincent Calvez; Stéphanie Cartalat-Carel; Linda Dainese; Jean-Yves Delattre; Emmanuel Grenier; Jérôme Honnorat; Ahmed Idbaih; Gentian Kaloshi; Johan Pallud; Mathieu Peyre; Dimitri Psimaras; François Ducray
A tumor growth inhibition model for low-grade glioma treated with chemotherapy or radiotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(18):5071-80.
2012: Damien Ricard; François Ducray; Khê Hoang-Xuan; Ahmed Idbaih; Marion Lahutte; Jean-Yves Delattre
Primary brain tumours in adults.
Lancet 2012;379(9830):1984-96.
2012: Jaime Gállego Pérez-Larraya; Alberto González-Aguilar; Rémy Guillevin; Khê Hoang-Xuan; Caroline Houillier; Marion Lahutte; Gregorio Petrirena; Germán Reyes-Botero; Marc Sanson; Jean-Yves Delattre
Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: comparative analysis of the Macdonald, RECIST, RANO, and RECIST + F criteria.
Neuro-oncology 2012;14(5):667-73.
2012: Iñigo Rojas-Marcos; J Honnorat; Geraldine Picard; Dimitri Psimaras; David Chinchón; Jean-Yves Delattre; Ellen Gelpi; Bruno Giometto; Francesc Graus
Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo--associated paraneoplastic cerebellar degeneration.
Neuro-oncology 2012;14(4):506-10.
2012: German Reyes-Botero; Jean-Yves Delattre; Nadine Martin-Duverneuil; Karima Mokhtari; Florence Laigle-Donadey
Adult brainstem gliomas.
The oncologist 2012;17(3):388-97.
2011: Virginie Desestret; François Ducray; Khê Hoang-Xuan; Ahmed Idbaih; Gentian Kaloshi; Marianne Labussière; Karima Mokhtari; Marc Polivka; Blandine Boisselier; Pietro Ciccarino; Emmanuelle Crinière; Jean-Yves Delattre; Andreas von Deimling; Marc Sanson
Prognostic stratification of gliomatosis cerebri by IDH1 R132H and INA expression.
Journal of neuro-oncology 2011;105(2):219-24.
2011: C Dehais; J-L Golmard; N Jouniaux-Delbez; A Liou; B K Nguyen; V Souvannavong; C Tadrist; Jean-Yves Delattre
[An evaluation of fatigue in patients with glioblastoma relapse treated with the combination of irinotecan-bevacizumab].
Revue neurologique 2011;167(11):841-6.
2011: Jean-Yves Delattre
[Glioblastoma in the elderly].
Revue neurologique 2011;167(10):680-2.
2011: Jaime Gállego Pérez-Larraya; Maryline Barrie; Patrick Beauchesne; Chantal Campello; Stéphanie Cartalat-Carel; Isabelle Catry-Thomas; Olivier Chinot; François Ducray; Jean-Sébastien Guillamo; Jérôme Honnorat; Aymeri Huchet; Mona Matta; Karima Mokhtari; Annick Monjour; Luc Taillandier; Marie-Laure Tanguy; Jean-Yves Delattre
Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(22):3050-5.
2011: Sylvain Rheims; Damien Ricard; Marc Sanson; Luc Taillandier; Martin van den Bent; Véronique Bourg; Stéphanie Cartalat-Carel; Jean-Yves Delattre; Virginie Désestret; Marc Hermier; Jérôme Honnorat; Annick Monjour; François Ducray
Peri-ictal pseudoprogression in patients with brain tumor.
Neuro-oncology 2011;13(7):775-82.
2011: Ahmed Idbaih; Cyril Dalmasso; Mathilde Kouwenhoven; Judith Jeuken; Catherine Carpentier; Thierry Gorlia; Johan M Kros; Pim French; Johannes Teepen; Philippe Broët; Olivier Delattre; Karima Mokhtari; Marc Sanson; Jean-Yves Delattre; Martin van den Bent; Khê Hoang-Xuan
Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951.
Journal of neuro-oncology 2011;103(2):221-30.
2011: Nicolas WEISS; Anthony Behin; Dimitri Psimaras; Jean-Yves Delattre
Postirradiation neuromyotonia of spinal accessory nerves.
Neurology 2011;76(13):1188-9.
2011: Florence Laigle-Donadey; Jean-Yves Delattre
[Glioblastoma in the elderly].
Gériatrie et psychologie neuropsychiatrie du vieillissement 2011;9(1):101-6.
2011: François Ducray; Monica Sierra del Rio; Catherine Carpentier; Dimitri Psimaras; Ahmed Idbaih; Caroline Dehais; Gentian Kaloshi; Karima Mokhtari; Sophie Taillibert; Florence Laigle-Donadey; Antonio M P Omuro; Marc Sanson; Jean-Yves Delattre; Khê Hoang-Xuan
Up-front temozolomide in elderly patients with anaplastic oligodendroglioma and oligoastrocytoma.
Journal of neuro-oncology 2011;101(3):457-62.
2011: Sandra-Nadia Ngwabyt Bikeye; Carole Colin; Yannick Marie; Raphaël Vampouille; Philippe Ravassard; Audrey Rousseau; Blandine Boisselier; Ahmed Idbaih; Charles-Félix Calvo; Pascal Leuraud; Myriam Lassalle; Soufiane El Hallani; Jean-Yves Delattre; Marc Sanson
Correction: ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target.
Cancer cell international 2011;11():10.
2011: julien laffaire; Sibille Everhard; Ahmed Idbaih; Emmanuelle Crinière; Yannick Marie; Aurelien de Reyniès; Renaud Schiappa; Karima Mokhtari; Khê Hoang-Xuan; Marc Sanson; Jean-Yves Delattre; Joëlle Thillet; François Ducray
Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis.
Neuro-oncology 2011;13(1):84-98.
2010: Blandine Boisselier; Yannick Marie; Marianne Labussière; Pietro Ciccarino; Virginie Desestret; XiaoWei Wang; Laurent Capelle; Jean-Yves Delattre; Marc Sanson
COLD PCR HRM: a highly sensitive detection method for IDH1 mutations.
Human mutation 2010;31(12):1360-5.
2010: C Houillier; X Wang; Gentian Kaloshi; Karima Mokhtari; Rémy Guillevin; julien laffaire; Sophie Paris; B Boisselier; Ahmed Idbaih; Florence Laigle-Donadey; Khê Hoang-Xuan; Marc Sanson; Jean-Yves Delattre
IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas.
Neurology 2010;75(17):1560-6.
2010: Florence Laigle-Donadey; Dominique Figarella-Branger; Olivier Chinot; Luc Taillandier; Stéphanie Cartalat-Carel; Jérôme Honnorat; Gentian Kaloshi; Jean-Yves Delattre; Marc Sanson
Up-front temozolomide in elderly patients with glioblastoma.
Journal of neuro-oncology 2010;99(1):89-94.
2010: M Labussière; Ahmed Idbaih; X-W Wang; Yannick Marie; B Boisselier; C Falet; Sophie Paris; julien laffaire; Catherine Carpentier; Emmanuelle Crinière; François Ducray; S El Hallani; Karima Mokhtari; Khê Hoang-Xuan; Jean-Yves Delattre; Marc Sanson
All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2.
Neurology 2010;74(23):1886-90.
2010: François Ducray; Aurélien de Reyniès; Olivier Chinot; Ahmed Idbaih; Dominique Figarella-Branger; Carole Colin; Lucie Karayan-Tapon; Hervé Chneiweiss; Michel Wager; François Vallette; Yannick Marie; David Rickman; Emilie Thomas; Jean-Yves Delattre; Jérôme Honnorat; Marc Sanson; François Berger
An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients.
Molecular cancer 2010;9():234.
2010: Caroline Houillier; Karima Mokhtari; Catherine Carpentier; Emmanuelle Crinière; Yannick Marie; Audrey Rousseau; Gentian Kaloshi; Caroline Dehais; julien laffaire; Florence Laigle-Donadey; Khê Hoang-Xuan; Marc Sanson; Jean-Yves Delattre
Chromosome 9p and 10q losses predict unfavorable outcome in low-grade gliomas.
Neuro-oncology 2010;12(1):2-6.
2010: Sandra-Nadia Ngwabyt Bikeye; Carole Colin; Yannick Marie; Raphaël Vampouille; Philippe Ravassard; Audrey Rousseau; Blandine Boisselier; Ahmed Idbaih; Charles-Félix Calvo; Pascal Leuraud; Myriam Lassalle; Soufiane El Hallani; Jean-Yves Delattre; Marc Sanson
ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target.
Cancer cell international 2010;10():1.
2010: Marianne Labussiere; Marc Sanson; Ahmed Idbaih; Jean-Yves Delattre
IDH1 gene mutations: a new paradigm in glioma prognosis and therapy?
The oncologist 2010;15(2):196-9.
2010: Ahmed Idbaih; Emmanuelle Crinière; Keith L Ligon; Olivier Delattre; Jean-Yves Delattre
Array-based genomics in glioma research.
Brain pathology (Zurich, Switzerland) 2010;20(1):28-38.
2009: Gentian Kaloshi; D Psimaras; Karima Mokhtari; C Dehais; C Houillier; Yannick Marie; Florence Laigle-Donadey; Sophie Taillibert; Rémy Guillevin; Nadine Martin-Duverneuil; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre
Supratentorial low-grade gliomas in older patients.
Neurology 2009;73(24):2093-8.
2009: Marc Sanson; Yannick Marie; Sophie Paris; Ahmed Idbaih; julien laffaire; François Ducray; Soufiane El Hallani; Blandine Boisselier; Karima Mokhtari; Khê Hoang-Xuan; Jean-Yves Delattre
Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(25):4150-4.
2009: Blandine Boisselier; Yannick Marie; Soufiane El Hallani; Gentian Kaloshi; Anton Iershov; Vadym Kavsan; Dimitri Psimaras; Joëlle Thillet; Khê Hoang-Xuan; Jean-Yves Delattre; Marc Sanson
No association of (-131C-->G) variant of CHI3L1 gene with risk of glioblastoma and prognosis.
Journal of neuro-oncology 2009;94(2):169-72.
2009: Gentian Kaloshi; Rémy Guillevin; Nadine Martin-Duverneuil; Florence Laigle-Donadey; D Psimaras; Yannick Marie; Karima Mokhtari; Khê Hoang-Xuan; Jean-Yves Delattre; Marc Sanson
Gray matter involvement predicts chemosensitivity and prognosis in gliomatosis cerebri.
Neurology 2009;73(6):445-9.
2009: Sibille Everhard; Jörg Tost; Hafida El Abdalaoui; Emmanuelle Crinière; Florence Busato; Yannick Marie; Ivo Gut; Marc Sanson; Karima Mokhtari; Florence Laigle-Donadey; Khê Hoang-Xuan; Jean-Yves Delattre; Joëlle Thillet
Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas.
Neuro-oncology 2009;11(4):348-56.
2009: Ahmed Idbaih; J Aimard; B Boisselier; Yannick Marie; Sophie Paris; Emmanuelle Crinière; R Carvalho Silva; Florence Laigle-Donadey; A Rousseau; Karima Mokhtari; Joëlle Thillet; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre
Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma.
Neuropathology and applied neurobiology 2009;35(2):208-13.
2009: S El Hallani; François Ducray; Ahmed Idbaih; Yannick Marie; B Boisselier; C Colin; Florence Laigle-Donadey; M Rodéro; O Chinot; Joëlle Thillet; Khê Hoang-Xuan; Jean-Yves Delattre; Marc Sanson
TP53 codon 72 polymorphism is associated with age at onset of glioblastoma.
Neurology 2009;72(4):332-6.
2009: F Ducray; E Crinière; Ahmed Idbaih; K Mokhtari; Y Marie; Sophie Paris; S Navarro; F Laigle-Donadey; C Dehais; Joëlle Thillet; Khê Hoang-Xuan; Jean-Yves Delattre; Marc Sanson
alpha-Internexin expression identifies 1p19q codeleted gliomas.
Neurology 2009;72(2):156-61.
2009: Magdalena Benetkiewicz; Ahmed Idbaih; Pierre-Yves Cousin; Blandine Boisselier; Yannick Marie; Emmanuelle Crinière; Khê Hoang-Xuan; Jean-Yves Delattre; Marc Sanson; Olivier Delattre
NOTCH2 is neither rearranged nor mutated in t(1;19) positive oligodendrogliomas.
PloS one 2009;4(1):e4107.
2008: Florence Laigle-Donadey; François Doz; Jean-Yves Delattre
Brainstem gliomas in children and adults.
Current opinion in oncology 2008;20(6):662-7.
2008: Ahmed Idbaih; Rosana Carvalho Silva; Emmanuelle Crinière; Yannick Marie; Catherine Carpentier; Blandine Boisselier; Sophie Taillibert; Audrey Rousseau; Karima Mokhtari; François Ducray; Joelle Thillet; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre
Genomic changes in progression of low-grade gliomas.
Journal of neuro-oncology 2008;90(2):133-40.
2008: Ahmed Idbaih; Emmanuelle Crinière; Yannick Marie; Audrey Rousseau; Karima Mokhtari; Michèle Kujas; Younas El Houfi; Catherine Carpentier; Sophie Paris; Blandine Boisselier; Florence Laigle-Donadey; Joëlle Thillet; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre
Gene amplification is a poor prognostic factor in anaplastic oligodendrogliomas.
Neuro-oncology 2008;10(4):540-7.
2008: Ahmed Idbaih; Mathilde Kouwenhoven; Judith Jeuken; Catherine Carpentier; Thierry Gorlia; Johan M Kros; Pim French; Johannes L Teepen; Olivier Delattre; Jean-Yves Delattre; Martin van den Bent; Khê Hoang-Xuan
Chromosome 1p loss evaluation in anaplastic oligodendrogliomas.
Neuropathology : official journal of the Japanese Society of Neuropathology 2008;28(4):440-3.
2008: François Ducray; Alexandra Benouaich-Amiel; Ahmed Idbaih; Audrey Rousseau; Florence Laigle-Donadey; Jean-Yves Delattre; Marc Sanson
Complete response after one cycle of temozolomide in an elderly patient with glioblastoma and poor performance status.
Journal of neuro-oncology 2008;88(2):185-8.
2008: Yuxia Meng; Michèle Kujas; Yannick Marie; Sophie Paris; Joëlle Thillet; Jean-Yves Delattre; Antoine F Carpentier
Expression of TLR9 within human glioblastoma.
Journal of neuro-oncology 2008;88(1):19-25.
2008: Ahmed Idbaih; Sophie Paris; Blandine Boisselier; Yannick Marie; Marc Sanson; Joëlle Thillet; Khê Hoang-Xuan; Jean-Yves Delattre
Mutational analysis of Rac2 in gliomas.
Journal of neuro-oncology 2008;87(3):365-6.
2008: Ahmed Idbaih; Yannick Marie; Carlo LUCCHESI; Gaëlle Pierron; Elodie Manié; Virginie Raynal; Véronique Mosseri; Khê Hoang-Xuan; Michèle Kujas; Isabel Brito; Karima Mokhtari; Marc Sanson; Emmanuel Barillot; Alain Aurias; Jean-Yves Delattre; Olivier Delattre
BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas.
International journal of cancer. Journal international du cancer 2008;122(8):1778-86.
2008: Ahmed Idbaih; Blandine Boisselier; Yannick Marie; Marc Sanson; Soufiane El Hallani; Emmanuelle Crinière; Maryam Fourtassi; Sophie Paris; Catherine Carpentier; Audrey Rousseau; Karima Mokhtari; Christophe Combadière; Florence Laigle-Donadey; Khê Hoang-Xuan; Jean-Yves Delattre
Influence of MDM2 SNP309 alone or in combination with the TP53 R72P polymorphism in oligodendroglial tumors.
Brain research 2008;1198():16-20.
2008: Gentian Kaloshi; Sibille Everhard; Florence Laigle-Donadey; Yannick Marie; Soledad Navarro; Karima Mokhtari; Ahmed Idbaih; François Ducray; Joëlle Thillet; Khê Hoang-Xuan; Jean-Yves Delattre; Marc Sanson
Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebri.
Neurology 2008;70(8):590-5.
2008: François Ducray; Ahmed Idbaih; Aurélien de Reyniès; Ivan Bièche; Joëlle Thillet; Karima Mokhtari; Séverine Lair; Yannick Marie; Sophie Paris; Michel Vidaud; Khê Hoang-Xuan; Olivier Delattre; Jean-Yves Delattre; Marc Sanson
Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile.
Molecular cancer 2008;7():41.
2007: Soufiane El Hallani; Yannick Marie; Ahmed Idbaih; Mathieu Rodero; Blandine Boisselier; Florence Laigle-Donadey; François Ducray; Jean-Yves Delattre; Marc Sanson
No association of MDM2 SNP309 with risk of glioblastoma and prognosis.
Journal of neuro-oncology 2007;85(3):241-4.
2007: Ahmed Idbaih; Blandine Boisselier; Yannick Marie; Soufiane El Hallani; Marc Sanson; Emmanuelle Crinière; Mathieu Rodero; Catherine Carpentier; Sophie Paris; Florence Laigle-Donadey; François Ducray; Khê Hoang-Xuan; Jean-Yves Delattre
TP53 codon 72 polymorphism, p53 expression, and 1p/19q status in oligodendroglial tumors.
Cancer genetics and cytogenetics 2007;177(2):103-7.
2007: Gentian Kaloshi; Karima Mokhtari; Catherine Carpentier; Sophie Taillibert; Julie Lejeune; Yannick Marie; Jean-Yves Delattre; Roseline Godbout; Marc Sanson
FABP7 expression in glioblastomas: relation to prognosis, invasion and EGFR status.
Journal of neuro-oncology 2007;84(3):245-8.
2007: Catherine Carpentier; Julie Lejeune; Florent Gros; Sibille Everhard; Yannick Marie; Gentian Kaloshi; Florence Laigle-Donadey; Khê Hoang-Xuan; Jean-Yves Delattre; Marc Sanson
Association of telomerase gene hTERT polymorphism and malignant gliomas.
Journal of neuro-oncology 2007;84(3):249-53.
2007: Ahmed Idbaih; Blandine Boisselier; Marc Sanson; Emmanuelle Crinière; Stéphane Liva; Yannick Marie; Catherine Carpentier; Sophie Paris; Florence Laigle-Donadey; Karima Mokhtari; Michèle Kujas; Khê Hoang-Xuan; Olivier Delattre; Jean-Yves Delattre
Tumor genomic profiling and TP53 germline mutation analysis of first-degree relative familial gliomas.
Cancer genetics and cytogenetics 2007;176(2):121-6.
2007: Emmanuelle Crinière; Gentian Kaloshi; Florence Laigle-Donadey; Julie Lejeune; Nathalie Auger; Alexandra Benouaich-Amiel; Sibille Everhard; Karima Mokhtari; Marc Polivka; Jean-Yves Delattre; Khê Hoang-Xuan; Joëlle Thillet; Marc Sanson
MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities.
Journal of neuro-oncology 2007;83(2):173-9.
2007: Gentian Kaloshi; Alexandra Benouaich-Amiel; F Diakite; Sophie Taillibert; Julie Lejeune; Florence Laigle-Donadey; M-A Renard; Wafae Iraqi; Ahmed Idbaih; Sophie Paris; Laurent Capelle; Hugues Duffau; Philippe Cornu; Jean-Marc Simon; Karima Mokhtari; Marc Polivka; Antonio M P Omuro; A Carpentier; Marc Sanson; Jean-Yves Delattre; Khê Hoang-Xuan
Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome.
Neurology 2007;68(21):1831-6.
2007: Damien Ricard; Gentian Kaloshi; Alexandra Amiel-Benouaich; Julie Lejeune; Yannick Marie; Emmanuel Mandonnet; Michèle Kujas; Karima Mokhtari; Sophie Taillibert; Florence Laigle-Donadey; Antoine F Carpentier; Antonio M P Omuro; Laurent Capelle; Hugues Duffau; Philippe Cornu; Rémy Guillevin; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre
Dynamic history of low-grade gliomas before and after temozolomide treatment.
Annals of neurology 2007;61(5):484-90.
2007: Florence Keime-Guibert; Olivier Chinot; Luc Taillandier; Stéphanie Cartalat-Carel; Marc Frenay; Guy Kantor; Jean-Sébastien Guillamo; Eric Jadaud; Philippe Colin; Pierre-Yves Bondiau; Philippe Meneï; Hugues Loiseau; Valérie Bernier; Jérôme Honnorat; Maryline Barrié; Karima Mokhtari; Jean-Jacques Mazeron; Alvine Bissery; Jean-Yves Delattre
Radiotherapy for glioblastoma in the elderly.
The New England journal of medicine 2007;356(15):1527-35.
2007: Elodie Vauleon; Nathalie Auger; Alexandra Benouaich-Amiel; Florence Laigle-Donadey; Gentian Kaloshi; Julie Lejeune; Jean-Yves Delattre; Joëlle Thillet; Marc Sanson
The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma.
Cancer genetics and cytogenetics 2007;172(1):33-7.
2006: Sibille Everhard; Gentian Kaloshi; Emmanuelle Crinière; Alexandra Benouaich-Amiel; Julie Lejeune; Yannick Marie; Marc Sanson; Michèle Kujas; Karima Mokhtari; Khê Hoang-Xuan; Jean-Yves Delattre; Joëlle Thillet
MGMT methylation: a marker of response to temozolomide in low-grade gliomas.
Annals of neurology 2006;60(6):740-3.
2006: Antonio M P Omuro; Claudia C Leite; Karima Mokhtari; Jean-Yves Delattre
Pitfalls in the diagnosis of brain tumours.
Lancet neurology 2006;5(11):937-48.
2006: Florence Laigle-Donadey; Jean-Yves Delattre
Glioma in the elderly.
Current opinion in oncology 2006;18(6):644-7.
2006: Caroline Dehais; Florence Laigle-Donadey; Yannick Marie; Michèle Kujas; Julie Lejeune; Alexandra Benouaich-Amiel; Marta Pedretti; Marc Polivka; Khe-Hoang Xuan; Joëlle Thillet; Jean-Yves Delattre; Marc Sanson
Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
Cancer 2006;107(8):1891-7.
2006: Catherine Carpentier; Florence Laigle-Donadey; Yannick Marie; Nathalie Auger; Alexandra Benouaich-Amiel; Julie Lejeune; Gentian Kaloshi; Jean-Yves Delattre; Joëlle Thillet; Marc Sanson
Polymorphism in Sp1 recognition site of the EGF receptor gene promoter and risk of glioblastoma.
Neurology 2006;67(5):872-4.
2006: Xavier Declèves; Alexandra Amiel; Jean-Yves Delattre; Jean-Michel Scherrmann
Role of ABC transporters in the chemoresistance of human gliomas.
Current cancer drug targets 2006;6(5):433-45.
2006: Caroline Houillier; Julie Lejeune; Alexandra Benouaich-Amiel; Florence Laigle-Donadey; Emmanuelle Criniere; Karima Mokhtari; Joëlle Thillet; Jean-Yves Delattre; Khê Hoang-Xuan; Marc Sanson
Prognostic impact of molecular markers in a series of 220 primary glioblastomas.
Cancer 2006;106(10):2218-23.
2006: Alexandra Benouaich-Amiel; Jean-Yves Delattre
[Update on cerebral tumors].
Bulletin du cancer 2006;93(1):73-81.
2006: Alexandre Carpentier; Florence Laigle-Donadey; Sarah Zohar; Laurent Capelle; Anthony Behin; Annick Tibi; Nadine Martin-Duverneuil; Marc Sanson; Lucette Lacomblez; Sophie Taillibert; Louis Puybasset; Rémy Van Effenterre; Jean-Yves Delattre; Antoine F Carpentier
Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma.
Neuro-oncology 2006;8(1):60-6.
2005: Alexandra Benouaich-Amiel; Jean-Marc Simon; Jean-Yves Delattre
[Concomitant radiotherapy with chemotherapy in patients with glioblastoma].
Bulletin du cancer 2005;92(12):1065-72.
2005: Georges Noel; Marc A Bollet; Sophie Noel; Loïc Feuvret; Gilbert Boisserie; Bernadette Tep; Jean-Yves Delattre; François Baillet; Charles Ambroise Valery; Philippe Cornu; Jean-Jacques Mazeron
Linac stereotactic radiosurgery: an effective and safe treatment for elderly patients with brain metastases.
International journal of radiation oncology, biology, physics 2005;63(5):1555-61.
2005: Yuxia Meng; Antoine F Carpentier; Lin Chen; Gilbert Boisserie; Jean-Marc Simon; Jean-Jacques Mazeron; Jean-Yves Delattre
Successful combination of local CpG-ODN and radiotherapy in malignant glioma.
International journal of cancer. Journal international du cancer 2005;116(6):992-7.
2005: Florence Laigle-Donadey; Sophie Taillibert; Nadine Martin-Duverneuil; Jerzy Hildebrand; Jean-Yves Delattre
Skull-base metastases.
Journal of neuro-oncology 2005;75(1):63-9.
2005: Florence Laigle-Donadey; Sophie Taillibert; Karima Mokhtari; Jerzy Hildebrand; Jean-Yves Delattre
Dural metastases.
Journal of neuro-oncology 2005;75(1):57-61.
2005: Ahmed Idbaih; Yannick Marie; Gaëlle Pierron; Caroline Brennetot; Khê Hoang-Xuan; Michèle Kujas; Karima Mokhtari; Marc Sanson; Julie Lejeune; Alain Aurias; Olivier Delattre; Jean-Yves Delattre
Two types of chromosome 1p losses with opposite significance in gliomas.
Annals of neurology 2005;58(3):483-7.
2005: Michèle Kujas; Julie Lejeune; Alexandra Benouaich-Amiel; Emmanuelle Crinière; Florence Laigle-Donadey; Yannick Marie; Karima Mokhtari; Marc Polivka; Michèle Bernier; fabrice Chretien; Anne Couvelard; Laurent Capelle; Hugues Duffau; Philippe Cornu; Philippe Broët; Joëlle Thillet; Antoine F Carpentier; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre
Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas.
Annals of neurology 2005;58(2):322-6.
2005: Jerzy Hildebrand; Cristel Lecaille; Joëlle Perennes; Jean-Yves Delattre
Epileptic seizures during follow-up of patients treated for primary brain tumors.
Neurology 2005;65(2):212-5.
2005: Yannick Marie; Antoine F Carpentier; Antonio M P Omuro; Marc Sanson; Joëlle Thillet; Khê Hoang-Xuan; Jean-Yves Delattre
EGFR tyrosine kinase domain mutations in human gliomas.
Neurology 2005;64(8):1444-5.
2005: A Rousseau; B Benyahia; J Dalmau; Francine Connan; Jean-Gérard Guillet; Jean-Yves Delattre; Jeannine Choppin
T cell response to Hu-D peptides in patients with anti-Hu syndrome.
Journal of neuro-oncology 2005;71(3):231-6.
2005: Karima Mokhtari; Sophie Paris; Lucinda Aguirre-Cruz; Nicolas Privat; Emmanuelle Crinière; Yannick Marie; JEAN-JACQUES HAUW; Michèle Kujas; D Rowitch; Khê Hoang-Xuan; Jean-Yves Delattre; Marc Sanson
Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification.
Neuropathology and applied neurobiology 2005;31(1):62-9.
2005: Lucinda Aguirre-Cruz; Jean-Luc Charuel; Antoine F Carpentier; Baya Benyahia; Jean-Yves Delattre; Lucile Musset
Clinical relevance of non-neuronal auto-antibodies in patients with anti-Hu or anti-Yo paraneoplastic diseases.
Journal of neuro-oncology 2005;71(1):39-41.
2004: Florence Laigle-Donadey; Nadine Martin-Duverneuil; Julie Lejeune; Emmanuelle Crinière; Laurent Capelle; Hugues Duffau; Philippe Cornu; Philippe Broët; Michèle Kujas; Karima Mokhtari; A Carpentier; Marc Sanson; Khê Hoang-Xuan; Joëlle Thillet; Jean-Yves Delattre
Correlations between molecular profile and radiologic pattern in oligodendroglial tumors.
Neurology 2004;63(12):2360-2.
2004: Anthony Béhin; Jean-Yves Delattre
Complications of radiation therapy on the brain and spinal cord.
Seminars in neurology 2004;24(4):405-17.
2004: A Lladó; P Mannucci; A F Carpentier; S Paris; Yolanda Blanco; Albert Saiz; Jean-Yves Delattre; Francesc Graus
Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes.
Neurology 2004;63(10):1947-9.
2004: C Lefèvre-Houillier; J-C Willer; Jean-Yves Delattre; Nadine Martin-Duverneuil
[Post-irradiation neuromyotonia of the masseter muscle].
Revue neurologique 2004;160(11):1075-7.
2004: Khê Hoang-Xuan; Laurent Capelle; Michèle Kujas; Sophie Taillibert; Hugues Duffau; Julie Lejeune; Marc Polivka; Emmanuelle Crinière; Yannick Marie; Karima Mokhtari; Antoine F Carpentier; F Laigle; Jean-Marc Simon; Philippe Cornu; Philippe Broët; Marc Sanson; Jean-Yves Delattre
Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(15):3133-8.
2004: Marc Sanson; Stéphanie Cartalat-Carel; Sophie Taillibert; Massimo Napolitano; L Djafari; J Cougnard; H Gervais; F Laigle; A Carpentier; Karima Mokhtari; Luc Taillandier; Olivier Chinot; Hugues Duffau; Jérôme Honnorat; Khê Hoang-Xuan; Jean-Yves Delattre
Initial chemotherapy in gliomatosis cerebri.
Neurology 2004;63(2):270-5.
2004: Pascal Leuraud; Luc Taillandier; Jacques Medioni; Lucinda Aguirre-Cruz; Emmanuelle Crinière; Yannick Marie; Michèle Kujas; Jean-Louis Golmard; Adrien Duprez; Jean-Yves Delattre; Marc Sanson; Marie-France Poupon
Distinct responses of xenografted gliomas to different alkylating agents are related to histology and genetic alterations.
Cancer research 2004;64(13):4648-53.
2004: Oriane Trouillard; Lucinda Aguirre-Cruz; Khê Hoang-Xuan; Yannick Marie; Jean-Yves Delattre; Marc Sanson
Parental 19q loss and PEG3 expression in oligodendrogliomas.
Cancer genetics and cytogenetics 2004;151(2):182-3.
2004: Georges Noël; Chiraz N Ben Ammar; Loïc Feuvret; Charles-Ambroise Valery; Philippe Cornu; Gilbert Boisserie; Jean-Marc Simon; Dominique Hasboun; Bernadette Tep; Jean-Yves Delattre; Marc Sanson; François Baillet; Jean-Jacques Mazeron
[Results of salvage stereotactic radiosurgery in 14 patients with grade III or IV gliomas].
Revue neurologique 2004;160(5 Pt 1):539-45.
2004: Charles Dichamp; Sophie Taillibert; Lucinda Aguirre-Cruz; Julie Lejeune; Yannick Marie; Michèle Kujas; Jean-Yves Delattre; Khê Hoang-Xuan; Marc Sanson
Loss of 14q chromosome in oligodendroglial and astrocytic tumors.
Journal of neuro-oncology 2004;67(3):281-5.
2004: Lucinda Aguirre-Cruz; Karima Mokhtari; Khê Hoang-Xuan; Yannick Marie; Emmanuelle Criniere; Sophie Taillibert; Manuel Lopes; Jean-Yves Delattre; Marc Sanson
Analysis of the bHLH transcription factors Olig1 and Olig2 in brain tumors.
Journal of neuro-oncology 2004;67(3):265-71.
2004: Pascal Leuraud; Edouard Dezamis; Lucinda Aguirre-Cruz; Sophie Taillibert; Julie Lejeune; Eric Robin; Karima Mokhtari; Anne-Laure Boch; Philippe Cornu; Jean-Yves Delattre; Marc Sanson
Prognostic value of allelic losses and telomerase activity in meningiomas.
Journal of neurosurgery 2004;100(2):303-9.
2004: B Benyahia; S Huguet; Xavier Declèves; Karima Mokhtari; Emmanuelle Crinière; Jean-François Bernaudin; Jean-Michel Scherrmann; Jean-Yves Delattre
Multidrug resistance-associated protein MRP1 expression in human gliomas: chemosensitization to vincristine and etoposide by indomethacin in human glioma cell lines overexpressing MRP1.
Journal of neuro-oncology 2004;66(1-2):65-70.
2004: Georges Noel; Charles-Ambroise Valery; Gilbert Boisserie; Philippe Cornu; Dominique Hasboun; Jean Marc Simon; Bernadette Tep; Dominique Ledu; Jean-Yves Delattre; Claude Marsault; François Baillet; Jean-Jacques Mazeron
LINAC radiosurgery for brain metastasis of renal cell carcinoma.
Urologic oncology 2004;22(1):25-31.
2003: Pascal Leuraud; Luc Taillandier; Lucinda Aguirre-Cruz; Jacques Medioni; Emmanuelle Crinière; Yannick Marie; Anne-Marie Dutrillaux; Michèle Kujas; A Duprez; Jean-Yves Delattre; Marie-France Poupon; Marc Sanson
Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice.
British journal of cancer 2003;89(12):2327-32.
2003: I Rojas-Marcos; David Calvet; P Janoray; Jean-Yves Delattre
Response of recurrent anaplastic ependymoma to a combination of tamoxifen and isotretinoin.
Neurology 2003;61(7):1019-20.
2003: Georges Noël; Sophie Noël; Loïc Feuvret; Charles-Ambroise Valery; Philippe Cornu; Gilbert Boisserie; Dominique Hasboun; Bernadette Tep; Jean-Yves Delattre; François Baillet; Jean-Jacques Mazeron
[Stereotaxic irradiation of brain metastasis in elderly patients].
Bulletin du cancer 2003;90(10):896-904.
2003: Elie Louis; Corina Cret; Jacques Poirier; Philippe Cornu; Nadine Martin-Duverneuil; Jean-Yves Delattre; Marc Sanson
Intra-cerebral schwannoma simulating glioma.
Journal of neuro-oncology 2003;64(3):279-82.
2003: Georges Noel; Jacques Medioni; Charles-Ambroise Valery; Gilbert Boisserie; Jean-Marc Simon; Philippe Cornu; Dominique Hasboun; Dominique Ledu; Bernadette Tep; Jean-Yves Delattre; Claude Marsault; François Baillet; Jean-Jacques Mazeron
Three irradiation treatment options including radiosurgery for brain metastases from primary lung cancer.
Lung cancer (Amsterdam, Netherlands) 2003;41(3):333-43.
2003: Khê Hoang-Xuan; Luc Taillandier; Olivier Chinot; P Soubeyran; U Bogdhan; J Hildebrand; Marc Frenay; N De Beule; Jean-Yves Delattre; B Baron
Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(14):2726-31.
2003: Georges Noël; Jean-Marc Simon; Charles-Ambroise Valery; Philippe Cornu; Gilbert Boisserie; Dominique Hasboun; Dominique Ledu; Bernadette Tep; Jean-Yves Delattre; Claude Marsault; François Baillet; Jean-Jacques Mazeron
Radiosurgery for brain metastasis: impact of CTV on local control.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;68(1):15-21.
2003: Pascal Leuraud; Lucinda Aguirre-Cruz; Khê Hoang-Xuan; Emmanuelle Crinière; Marie-Laure Tanguy; Jean-Louis Golmard; Michèle Kujas; Jean-Yves Delattre; Marc Sanson
Telomerase reactivation in malignant gliomas and loss of heterozygosity on 10p15.1.
Neurology 2003;60(11):1820-2.
2003: Iñigo Rojas-Marcos; Audrey Rousseau; Florence Keime-Guibert; Ramón Reñé; Stéphanie Cartalat-Carel; Jean-Yves Delattre; Francesc Graus
Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer.
Medicine 2003;82(3):216-23.
2003: B Benyahia; Z Amoura; A Rousseau; C Le Clanche; A Carpentier; J C Piette; Jean-Yves Delattre
Paraneoplastic antineuronal antibodies in patients with systemic autoimmune diseases.
Journal of neuro-oncology 2003;62(3):349-51.
2003: Baya Benyahia; Antoine F Carpentier; Jean-Yves Delattre
[Antineuron antibodies and paraneoplastic neurological syndromes].
Revue neurologique 2003;159(4):463-5.
2003: Jean-Marc Simon; Georges Noël; Jacques Chiras; Khê Hoang-Xuan; Jean-Yves Delattre; François Baillet; Jean-Jacques Mazeron
Radiotherapy and chemotherapy with or without carbogen and nicotinamide in inoperable biopsy-proven glioblastoma multiforme.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;67(1):45-51.
2003: Emmanuel Mandonnet; Jean-Yves Delattre; Marie-Laure Tanguy; Kristin Swanson; Antoine F Carpentier; Hugues Duffau; Philippe Cornu; Rémy Van Effenterre; Ellsworth C Alvord; Laurent Capelle
Continuous growth of mean tumor diameter in a subset of grade II gliomas.
Annals of neurology 2003;53(4):524-8.
2003: E Louis; Nadine Martin-Duverneuil; Antoine F Carpentier; J-M Mayer; Jean-Yves Delattre
[Radiation-induced aneurysm of the cavernous internal carotid artery].
Revue neurologique 2003;159(3):319-22.
2003: Anthony Behin; Khê Hoang-Xuan; Antoine F Carpentier; Jean-Yves Delattre
Primary brain tumours in adults.
Lancet 2003;361(9354):323-31.
2003: Elie Louis; Florence Keime-Guibert; Jean-Yves Delattre; Marc Sanson
Dramatic response to chemotherapy in oligodendroglial gliomatosis cerebri.
Neurology 2003;60(1):151.
2003: Antoine F Carpentier; Gregor Auf; Jean-Yves Delattre
CpG-oligonucleotides for cancer immunotherapy : review of the literature and potential applications in malignant glioma.
Frontiers in bioscience : a journal and virtual library 2003;8():e115-27.
2002: Marc Sanson; Pascal Leuraud; Lucinda Aguirre-Cruz; Jié He; Yannick Marie; Stéphanie Cartalat-Carel; Karima Mokhtari; Hugues Duffau; Jean-Yves Delattre; Khê Hoang-Xuan
Analysis of loss of chromosome 10q, DMBT1 homozygous deletions, and PTEN mutations in oligodendrogliomas.
Journal of neurosurgery 2002;97(6):1397-401.
2002: Gregor Auf; Lin Chen; Paul Fornès; Christelle Le Clanche; Jean-Yves Delattre; Antoine F Carpentier
CpG-oligodeoxynucleotide rejection of a neuroblastoma in A/J mice does not induce a paraneoplastic disease.
Neuroscience letters 2002;327(3):189-92.
2002: Marc Sanson; Pascal Leuraud; Yannick Marie; Jean-Yves Delattre; Khê Hoang-Xuan
Preferential loss of paternal 19q, but not 1p, alleles in oligodendrogliomas.
Annals of neurology 2002;52(1):105-7.
2002: F Laigle; Nadine Martin-Duverneuil; A Carpentier; Khê Hoang-Xuan; Jean-Yves Delattre
Seizure-related contrast enhancement of a ganglioglioma.
Neurology 2002;58(10):1538.
2002: Jean-Marc Simon; Philippe Cornu; Gilbert Boisserie; Dominique Hasboun; Bernadette Tep; Claire Hardiman; Charles-Ambroise Valery; Jean-Yves Delattre; Dominique Dormont; François Baillet; Jean-Jacques Mazeron
Brachytherapy of glioblastoma recurring in previously irradiated territory: predictive value of tumor volume.
International journal of radiation oncology, biology, physics 2002;53(1):67-74.
2002: Stéphanie Cartalat-Carel; P F Pradat; A Carpentier; Jean-Yves Delattre
[Chronic meningitis before diagnosis of celiac disease].
Revue neurologique 2002;158(4):467-9.
2002: Georges Noël; Jean-Marc Simon; Charles-Ambroise Valery; Philippe Cornu; Gilbert Boisserie; Dominique Ledu; Dominique Hasboun; Bernadette Tep; Jean-Yves Delattre; Claude Marsault; François Baillet; Jean-Jacques Mazeron
Linac radiosurgery for brain metastasis of melanoma.
Stereotactic and functional neurosurgery 2002;79(3-4):245-55.
2002: Anthony Behin; M Lopes; Antoine F Carpentier; Jacques Chiras; Jean-Yves Delattre
[Paraplegia disclosing an intracranial arterovenous fistula with perimedullary drainage].
Revue neurologique 2002;158(1):70-3.
2001: C Denier; Antoine F Carpentier; Karima Mokhtari; Jean-Yves Delattre
[Cerebral glioblastomas and systemic metastases].
Revue neurologique 2001;157(12):1531-4.
2001: Jean-Sébastien Guillamo; François Doz; Jean-Yves Delattre
Brain stem gliomas.
Current opinion in neurology 2001;14(6):711-5.
2001: Jean-Sébastien Guillamo; A Monjour; Luc Taillandier; Bertrand Devaux; Pascale Varlet; C Haie-Meder; Gilles-Louis Defer; P Maison; J J Mazeron; Philippe Cornu; Jean-Yves Delattre
Brainstem gliomas in adults: prognostic factors and classification.
Brain : a journal of neurology 2001;124(Pt 12):2528-39.
2001: Gregor Auf; Antoine F Carpentier; Lin Chen; C Le Clanche; Jean-Yves Delattre
Implication of macrophages in tumor rejection induced by CpG-oligodeoxynucleotides without antigen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(11):3540-3.
2001: Khê Hoang-Xuan; Jié He; S Huguet; Karima Mokhtari; Yannick Marie; Michèle Kujas; Pascal Leuraud; Laurent Capelle; Jean-Yves Delattre; J Poirier; Philippe Broët; Marc Sanson
Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression.
Neurology 2001;57(7):1278-81.
2001: Jié He; Karima Mokhtari; Marc Sanson; Yannick Marie; Michèle Kujas; S Huguet; Pascal Leuraud; Laurent Capelle; Jean-Yves Delattre; J Poirier; Khê Hoang-Xuan
Glioblastomas with an oligodendroglial component: a pathological and molecular study.
Journal of neuropathology and experimental neurology 2001;60(9):863-71.
2001: Antoine F Carpentier; B Chassande; Zahir Amoura; Baya Benyahia; J C Piette; Jean-Yves Delattre
Systemic lupus erythematosus with anti-Hu antibodies and polyradiculoneuropathy.
Neurology 2001;57(3):558-9.
2001: Yannick Marie; Marc Sanson; Karima Mokhtari; Pascal Leuraud; Michèle Kujas; Jean-Yves Delattre; J Poirier; B Zalc; Khê Hoang-Xuan
OLIG2 as a specific marker of oligodendroglial tumour cells.
Lancet 2001;358(9278):298-300.
2001: C Lafitte; Zahir Amoura; P Cacoub; Pascale Pradat-Diehl; C Picq; F Salachas; J M Léger; Jean-Charles Piette; Jean-Yves Delattre
Neurological complications of primary Sjögren's syndrome.
Journal of neurology 2001;248(7):577-84.
2001: Georges Noël; MA Proudhom; Charles-Ambroise Valery; Philippe Cornu; Gilbert Boisserie; Dominique Hasboun; Jean-Marc Simon; Loïc Feuvret; Hugues Duffau; Bernadette Tep; Jean-Yves Delattre; Claude Marsault; Jacques Philippon; Denis Fohanno; François Baillet; Jean-Jacques Mazeron
Radiosurgery for re-irradiation of brain metastasis: results in 54 patients.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2001;60(1):61-7.
2001: Francesc Graus; Florence Keime-Guibert; R Reñe; Baya Benyahia; Teresa Ribalta; C Ascaso; G Escaramis; Jean-Yves Delattre
Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients.
Brain : a journal of neurology 2001;124(Pt 6):1138-48.
2001: Antoine F Carpentier; Jean-Yves Delattre
The Lambert-Eaton myasthenic syndrome.
Clinical reviews in allergy & immunology 2001;20(1):155-8.
2001: Dan Milea; M Napolitano; H Dechy; Phuc Le Hoang; Jean-Yves Delattre; Charles Pierrot-Deseilligny
Complete bilateral horizontal gaze paralysis disclosing multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 2001;70(2):252-5.
2000: Marc Sanson; M Napolitano; R Yaya; Florence Keime-Guibert; Philippe Broët; Khê Hoang-Xuan; Jean-Yves Delattre
Second line chemotherapy with docetaxel in patients with recurrent malignant glioma: a phase II study.
Journal of neuro-oncology 2000;50(3):245-9.
2000: Jié He; Khê Hoang-Xuan; Yannick Marie; Pascal Leuraud; Karima Mokhtari; Michèle Kujas; Jean-Yves Delattre; Marc Sanson
P18 tumor suppressor gene and progression of oligodendrogliomas to anaplasia.
Neurology 2000;55(6):867-9.
2000: I Rojas; Francesc Graus; Florence Keime-Guibert; Ramón Reñé; Jean-Yves Delattre; J M Ramón; J Dalmau; Jerome B Posner
Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies.
Neurology 2000;55(5):713-5.
2000: E Jalladeau; Antoine F Carpentier; M Napolitano; Jean-Yves Delattre
[Corticosteroid-induced epidural lipomatosis].
Revue neurologique 2000;156(5):517-9.
2000: Florence Keime-Guibert; Francesc Graus; A Fleury; R René; Jérôme Honnorat; P Broet; Jean-Yves Delattre
Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone.
Journal of neurology, neurosurgery, and psychiatry 2000;68(4):479-82.
2000: C Mallecourt; Jean-Yves Delattre
[Paraneoplastic neuropathies].
Presse médicale (Paris, France : 1983) 2000;29(8):447-52.
2000: V Navarro; Emmanuel Fournier; S Girard; Jean-Yves Delattre; Bruno Eymard
[Periodic hypokalemic paralysis as the manifestation of Graves' disease: clinical and electrophysiological study].
Revue neurologique 2000;156(1):59-61.
1999: X P Zhou; Marc Sanson; Khê Hoang-Xuan; Eric Robin; Luc Taillandier; Jié He; Karima Mokhtari; Philippe Cornu; Jean-Yves Delattre; G Thomas; R Hamelin
Germline mutations of p53 but not p16/CDKN2 or PTEN/MMAC1 tumor suppressor genes predispose to gliomas. The ANOCEF Group. Association des NeuroOncologues d'Expression Française.
Annals of neurology 1999;46(6):913-6.
1999: Florence Keime-Guibert; Francesc Graus; Philippe Broët; Ramón Reñé; José L Molinuevo; C Ascaso; Jean-Yves Delattre
Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor.
Neurology 1999;53(8):1719-23.
1999: A F Carpentier; L Chen; F Maltonti; Jean-Yves Delattre
Oligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastoma in mice.
Cancer research 1999;59(21):5429-32.
1999: P F Pradat; Khê Hoang-Xuan; Philippe Cornu; Karima Mokhtari; Nadine Martin-Duverneuil; M Poisson; Jean-Yves Delattre
Treatment of meningeal gliomatosis.
Journal of neuro-oncology 1999;44(2):163-8.
1999: Khê Hoang-Xuan; Jean-Yves Delattre
Ongoing protocols for non-AIDS primary central nervous system lymphoma.
Journal of neuro-oncology 1999;43(3):287-91.
1999: Loïc Feuvret; I Germain; Philippe Cornu; Gilbert Boisserie; Georges Noël; Claire Hardiman; Bernadette Tep; Dominique Hasboun; Thierry Faillot; Hugues Duffau; Charles-Ambroise Valery; Jean-Yves Delattre; M Poisson; Claude Marsault; Jacques Philippon; Denis Fohanno; François Baillet; Jean-Jacques Mazeron
[First treatment for brain metastases by stereotactic radiosurgery].
Bulletin du cancer 1999;86(7-8):666-72.
1999: M Napolitano; Florence Keime-Guibert; A Monjour; C Lafitte; A Ameri; Philippe Cornu; Philippe Broët; Jean-Yves Delattre
Treatment of supratentorial glioblastoma multiforme with radiotherapy and a combination of BCNU and tamoxifen: a phase II study.
Journal of neuro-oncology 1999;45(3):229-35.
1998: Florence Keime-Guibert; M Napolitano; Jean-Yves Delattre
Neurological complications of radiotherapy and chemotherapy.
Journal of neurology 1998;245(11):695-708.
1998: Loïc Feuvret; I Germain; Philippe Cornu; Gilbert Boisserie; Dominique Dormont; Claire Hardiman; Bernadette Tep; Thierry Faillot; Hugues Duffau; Jean-Marc Simon; Rémi Dendale; Jean-Yves Delattre; M Poisson; Claude Marsault; Jacques Philippon; Denis Fohanno; François Baillet; Jean-Jacques Mazeron
[Importance of radiotherapy in stereotactic conditions (radiosurgery) in brain metastasis: experience and results of the Hôpital Pitié-Salpêtrière Group].
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 1998;2(3):272-81.
1998: M Uchuya; A Fleury; Francesc Graus; Dominique Costagliola; Roland S Liblau; Hélène Merle-Beral; I Théodorou; Jean-Yves Delattre
Lack of association between human leukocyte antigens and the anti-Hu syndrome in patients with small-cell lung cancer.
Neurology 1998;50(2):565-6.
1998: Florence Keime-Guibert; Jean-Yves Delattre
[Update on neuro-oncology].
Bulletin du cancer 1998;85(1):53-6.
1997: S Alamowitch; Francesc Graus; M Uchuya; Ramón Reñé; E Bescansa; Jean-Yves Delattre
Limbic encephalitis and small cell lung cancer. Clinical and immunological features.
Brain : a journal of neurology 1997;120 ( Pt 6)():923-8.
1997: A Ameri; M Poisson; L Chauveinc; Q M Chen; Jean-Yves Delattre
Treatment of recurrent malignant supratentorial gliomas with the association of carboplatin and etoposide: a phase II study.
Journal of neuro-oncology 1997;32(2):155-60.
1997: A Fleury; François Menegoz; Pascale Grosclaude; Jean-Pierre Daures; Michel Henry-Amar; Nicole Raverdy; P Schaffer; M Poisson; Jean-Yves Delattre
Descriptive epidemiology of cerebral gliomas in France.
Cancer 1997;79(6):1195-202.
1996: M Sanson; A Ameri; A Monjour; T Sahmoud; P Ronchin; M Poisson; Jean-Yves Delattre
Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II study.
European journal of cancer (Oxford, England : 1990) 1996;32A(13):2229-35.
1996: A F Carpentier; Jean-Yves Delattre
[Immunological diagnosis of paraneoplastic neurologic syndromes].
Presse médicale (Paris, France : 1983) 1996;25(37):1835-8.
1996: Jean-Yves Delattre; JZ Salama; Jean-Luc Dumas; F Gray
[Conference at the Salpêtrière. 1995 January. Progressive multifocal cerebral involvement in a 70-year-old woman].
Revue neurologique 1996;152(11):711-7.
1996: A F Carpentier; L Bernard; M Poisson; Jean-Yves Delattre
[Central nervous system infections in patients with malignant diseases].
Revue neurologique 1996;152(10):587-601.
1996: Thierry Faillot; H Magdelénat; E Mady; Paul Steinfeld; Denis Fohanno; P Gropp; M Poisson; Jean-Yves Delattre
A phase I study of an anti-epidermal growth factor receptor monoclonal antibody for the treatment of malignant gliomas.
Neurosurgery 1996;39(3):478-83.
1996: M C Vigliani; N Sichez; M Poisson; Jean-Yves Delattre
A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results.
International journal of radiation oncology, biology, physics 1996;35(3):527-33.
1996: Jean-Yves Delattre; M Uchuya
Radiotherapy and chemotherapy for gliomas.
Current opinion in oncology 1996;8(3):196-203.
1996: M Uchuya; Francesc Graus; F Vega; Ramón Reñé; Jean-Yves Delattre
Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies.
Journal of neurology, neurosurgery, and psychiatry 1996;60(4):388-92.
1996: N Sichez; G Chatellier; M Poisson; Jean-Yves Delattre
[Supratentorial gliomas: neuropsychological study of long-term survivors].
Revue neurologique 1996;152(4):261-6.
1996: G Stragliotto; F Vega; Paul Steinfeld; P Gropp; M Poisson; Jean-Yves Delattre
Multiple infusions of anti-epidermal growth factor receptor (EGFR) monoclonal antibody (EMD 55,900) in patients with recurrent malignant gliomas.
European journal of cancer (Oxford, England : 1990) 1996;32A(4):636-40.
1996: C Lafitte; Jérôme Servan; J M Bleibel; Bertrand Wechsler; Jean-Yves Delattre
[Meningomyelitis disclosing Behçet's disease].
Revue neurologique 1996;152(3):205-7.
1996: Khê Hoang-Xuan; Jean-Yves Delattre
[Chemotherapy of primary malignant brain tumors in adults].
La Revue du praticien 1996;46(4):450-6.
1996: L Chauveinc; M T Sola-Martinez; M Martin-Duverneuil; Jean-Jacques Mazeron; Thierry Faillot; Philippe Cornu; Laurent Capelle; Jean-Yves Delattre; M Poisson; François Baillet; Jacques Chiras
Intra arterial chemotherapy with ACNU and radiotherapy in inoperable malignant gliomas.
Journal of neuro-oncology 1996;27(2):141-7.
1996: R J Freilich; Jean-Yves Delattre; A Monjour; Lisa De Angelis
Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients.
Neurology 1996;46(2):435-9.
1996: Gilbert Boisserie; Philippe Cornu; Dominique Dormont; M Sahel; Claire Hardiman; Bernadette Tep; A M Mandin; C Barret; Thierry Faillot; Jean-Yves Delattre; A Monjour; M Poisson; Claude Marsault; Jacques Philippon; Jean-Marc Simon; François Baillet; Jean-Jacques Mazeron
[Iridium 192 brachytherapy of supra-tentorial high grade glioma recurring in irradiated areas: technique and preliminary results of the Pitié-Salpêtrière hospital group].
Bulletin du cancer. Radiothérapie : journal de la Société française du cancer : organe de la société française de radiothérapie oncologique 1996;83(3):144-52.
1995: Y J Li; M Sanson; Khê Hoang-Xuan; Jean-Yves Delattre; M Poisson; Gilles Thomas; Richard Hamelin
Incidence of germ-line p53 mutations in patients with gliomas.
International journal of cancer. Journal international du cancer 1995;64(6):383-7.
1995: M Sarazin; A Ameri; A Monjour; A Nibio; M Poisson; Jean-Yves Delattre
Primary central nervous system lymphoma: treatment with chemotherapy and radiotherapy.
European journal of cancer (Oxford, England : 1990) 1995;31A(12):2003-7.
1995: Y J Li; Khê Hoang-Xuan; Jean-Yves Delattre; M Poisson; Gilles Thomas; Richard Hamelin
Frequent loss of heterozygosity on chromosome 9, and low incidence of mutations of cyclin-dependent kinase inhibitors p15 (MTS2) and p16 (MTS1) genes in gliomas.
Oncogene 1995;11(3):597-600.
1995: O Felician; Jean-Luc Renard; F Vega; A Créange; Q M Chen; D Bequet; Jean-Yves Delattre
Paraneoplastic cerebellar degeneration with anti-Yo antibody in a man.
Neurology 1995;45(6):1226-7.
1995: Jérôme Servan; F Marchand; L Garma; Danielle Seilhean; JEAN-JACQUES HAUW; Jean-Yves Delattre
[Narcolepsy disclosing neurosarcoidosis].
Revue neurologique 1995;151(4):281-3.
1995: M Poisson; G Stragliotto; G Davila; Charles Duyckaerts; Jean-Yves Delattre
[Gliomatous meningitis of hemispheric tumors. Study of 22 cases in adults].
Revue neurologique 1995;151(3):177-89.
1995: Khê Hoang-Xuan; P Merel; F Vega; J P Hugot; Philippe Cornu; Jean-Yves Delattre; M Poisson; Gilles Thomas; Olivier Delattre
Analysis of the NF2 tumor-suppressor gene and of chromosome 22 deletions in gliomas.
International journal of cancer. Journal international du cancer 1995;60(4):478-81.
1995: Francesc Graus; Jean-Yves Delattre
Immune modulation of paraneoplastic neurologic disorders.
Clinical neurology and neurosurgery 1995;97(1):112-6.
1995: J L Thibault; B Mercier; R Roos-Weil; M Sanson; Jean-Yves Delattre
[Peripheral neurological complications of Epstein-Barr virus infection].
Revue neurologique 1995;151(2):142-4.
1995: Ioannis Lamproglou; Qin M Chen; Gilbert Boisserie; Jean-Jacques Mazeron; M Poisson; François Baillet; M Le Poncin; Jean-Yves Delattre
Radiation-induced cognitive dysfunction: an experimental model in the old rat.
International journal of radiation oncology, biology, physics 1995;31(1):65-70.
1995: Josep Dalmau; Francesc Graus; Nai-Kong V Cheung; Marc K Rosenblum; Alan L. Ho; A Cañete; Jean-Yves Delattre; S J Thompson; Jerome B Posner
Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer.
Cancer 1995;75(1):99-109.
1994: Francesc Graus; I Bonaventura; M Uchuya; Josep Valls-Solé; Ramón Reñé; J M Leger; Eduardo Tolosa; Jean-Yves Delattre
Indolent anti-Hu-associated paraneoplastic sensory neuropathy.
Neurology 1994;44(12):2258-61.
1994: F Vega; Francesc Graus; Q M Chen; M Poisson; E Schuller; Jean-Yves Delattre
Intrathecal synthesis of the anti-Hu antibody in patients with paraneoplastic encephalomyelitis or sensory neuronopathy: clinical-immunologic correlation.
Neurology 1994;44(11):2145-7.
1994: P F Pradat; M Poisson; Jean-Yves Delattre
[Radiation-induced neuropathies. Experimental and clinical data].
Revue neurologique 1994;150(10):664-77.
1994: Martine Muleris; A Almeida; Anne-Marie Dutrillaux; E Pruchon; F Vega; Jean-Yves Delattre; M Poisson; Bernard Malfoy; Bernard Dutrillaux
Oncogene amplification in human gliomas: a molecular cytogenetic analysis.
Oncogene 1994;9(9):2717-22.
1994: A F Carpentier; M Sanson; Michèle Kujas; M Giroud; M Poisson; Jean-Yves Delattre
[Primary meningeal gliomatosis].
Revue neurologique 1994;150(3):232-5.
1994: Hugues Chabriat; Q M Chen; M Poisson; Jean-Yves Delattre
[Paraneoplastic cerebellar degeneration].
Revue neurologique 1994;150(2):105-14.
1993: A Ameri; M Poisson; Q M Chen; Jean-Yves Delattre
Treatment of recurrent malignant supratentorial gliomas with the association of procarbazine, thiotepa and vincristine: a phase II study.
Journal of neuro-oncology 1993;17(1):43-6.
1993: G Davila; Charles Duyckaerts; J P Lazareth; M Poisson; Jean-Yves Delattre
Diffuse primary leptomeningeal gliomatosis.
Journal of neuro-oncology 1993;15(1):45-9.
1993: F Vega; L Davila; Jean-Yves Delattre; G Said; J Vilcoq; J C Rosenwald; H Magdelenat; M Poisson
Experimental carcinomatous plexopathy.
Journal of neurology 1993;240(1):54-8.
1992: F Valldeoriola; F Vega; Ramón Reñé; A Pou; Jaume Roquer; Jean-Yves Delattre; Francesc Graus
[Neurologic syndromes associated with anti-Hu antibody. Study of 24 patients].
Medicina clínica 1992;99(10):361-4.
1992: F Vega; L Davila; G Chatellier; Jacques Chiras; francois fauchon; Philippe Cornu; Laurent Capelle; M Poisson; Jean-Yves Delattre
Treatment of malignant gliomas with surgery, intraarterial chemotherapy with ACNU and radiation therapy.
Journal of neuro-oncology 1992;13(2):131-5.
1992: Francesc Graus; F Vega; Jean-Yves Delattre; I Bonaventura; Ramón Reñé; D Arbaiza; Eduardo Tolosa
Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies.
Neurology 1992;42(3 Pt 1):536-40.
1992: M Poisson; Jacques Chiras; francois fauchon; Jean-Yves Delattre
[Treatment of supratentorial glioma in adults by intra-arterial HECNU. Experience of the Pitié-Salpétrière group].
Revue neurologique 1992;148(6-7):441-7.
1992: A Monjour; M Poisson; M Kujas; Jean-Yves Delattre
[Primary non-Hodgkin's malignant lymphoma of the central nervous system].
Revue neurologique 1992;148(10):589-600.
1991: M Poisson; Yann Péréon; Jacques Chiras; Jean-Yves Delattre
Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA).
Journal of neuro-oncology 1991;10(2):139-44.
1991: Jean-Yves Delattre; L Davila; F Vega; M Poisson
[Autoimmunity and paraneoplastic neurologic syndromes].
Revue neurologique 1991;147(8-9):549-56.
1990: francois fauchon; L Davila; G Chatellier; Denis Fohanno; Jacques Philippon; A Rey; Jacques Chiras; M Poisson; Jean-Yves Delattre
Treatment of malignant gliomas with surgery, intra-arterial infusions of 1-(2-hydroxyethyl)chloroethylnitrosourea, and radiation therapy: a phase II study.
Neurosurgery 1990;27(2):231-4.
1990: Khê Hoang-Xuan; Jean-Yves Delattre; M Poisson
Stevens-Johnson syndrome in a patient receiving cranial irradiation and carbamazepine.
Neurology 1990;40(7):1144-5.
1990: M Poisson; Jacques Chiras; francois fauchon; C Debussche; Jean-Yves Delattre
Treatment of malignant recurrent glioma by intra-arterial, infra-ophthalmic infusion of HECNU 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl) urea. A phase II study.
Journal of neuro-oncology 1990;8(3):255-62.
1990: Jean-Yves Delattre; C Castelain; L Davila; B Schadeck; M Poisson
[Metastasis to the pituitary stalk in a case of breast cancer].
Revue neurologique 1990;146(6-7):455-6.
1990: Jean-Yves Delattre; M al Sabagh; J P Bataini; M Poisson
[Cerebral necrosis found 13 years after irradiation of osteosarcoma of the cranial vault].
Revue neurologique 1990;146(5):364-7.
1989: Marc K Rosenblum; Jean-Yves Delattre; R W Walker; W R Shapiro
Fatal necrotizing encephalopathy complicating treatment of malignant gliomas with intra-arterial BCNU and irradiation: a pathological study.
Journal of neuro-oncology 1989;7(3):269-81.
1989: Lisa De Angelis; Jean-Yves Delattre; Jerome B Posner
Radiation-induced dementia in patients cured of brain metastases.
Neurology 1989;39(6):789-96.
1989: Jean-Yves Delattre; E Arbit; Howard T Thaler; Marc K Rosenblum; Jerome B Posner
A dose-response study of dexamethasone in a model of spinal cord compression caused by epidural tumor.
Journal of neurosurgery 1989;70(6):920-5.
1989: Jean-Yves Delattre; R W Walker; Marc K Rosenblum
Leptomeningeal gliomatosis with spinal cord or cauda equina compression: a complication of supratentorial gliomas in adults.
Acta neurologica Scandinavica 1989;79(2):133-9.
1988: Jean-Yves Delattre; Marc K Rosenblum; Howard T Thaler; L Mandell; W R Shapiro; Jerome B Posner
A model of radiation myelopathy in the rat. Pathology, regional capillary permeability changes and treatment with dexamethasone.
Brain : a journal of neurology 1988;111 ( Pt 6)():1319-36.
1988: Jean-Yves Delattre; Z Fuks; George Krol; D A Rottenberg; Jerome B Posner
Cerebral necrosis following neutron radiation of an extracranial tumor.
Journal of neuro-oncology 1988;6(2):113-7.
1988: Jean-Yves Delattre; E Arbit; Marc K Rosenblum; Howard T Thaler; N Lau; J H Galicich; Jerome B Posner
High dose versus low dose dexamethasone in experimental epidural spinal cord compression.
Neurosurgery 1988;22(6 Pt 1):1005-7.
1988: Jean-Yves Delattre; B Safai; Jerome B Posner
Erythema multiforme and Stevens-Johnson syndrome in patients receiving cranial irradiation and phenytoin.
Neurology 1988;38(2):194-8.